by Seini Moimoi | Aug 29, 2018
KaNDy is developing NT-814 for the treatment of common, chronic debilitating female sex-hormone related conditions, with an initial focus on symptoms of the menopause. 
by Seini Moimoi | May 22, 2018
Sublimity Therapeutics is a biotechnology company developing therapies for the treatment of ulcerative colitis. 
by Seini Moimoi | May 14, 2018
Neurana is a biotechnology company developing tolperisone, a novel, patented skeletal muscle relaxant for the treatment of acute, painful muscle spasms without sedation. 
by Seini Moimoi | Apr 3, 2018
Axonics is a medical technology company developing a miniaturized rechargeable implantable neuromodulation technology to treat urinary and fecal dysfunction. 
by Seini Moimoi | Apr 3, 2018
Poseida is translating best-in-class gene engineering technologies into CAR T-cell immunotherapies for multiple myeloma, prostate and other cancers, as well as gene therapies for orphan diseases.